Komal Jhaveri
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Kettering University(US)Massachusetts General Hospital(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Estrogen and related hormone effects
Most-Cited Works
- → The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers(2018)979 cited
- → HER kinase inhibition in patients with HER2- and HER3-mutant cancers(2018)769 cited
- → Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer(2023)618 cited
- → Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial(2023)378 cited
- → Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors(2019)286 cited
- → Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer(2022)281 cited